|
1
|
Braun J and Sieper J: Ankylosing
spondylitis. Lancet. 369:1379–1390. 2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang R and Ward MM: Epidemiology of axial
spondyloarthritis: An update. Curr Opin Rheumatol. 30:137–143.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
van Tubergen A: The changing clinical
picture and epidemiology of spondyloarthritis. Nat Rev Rheumatol.
11:110–118. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Salehi E, Eftekhari R, Oraei M, Gharib A
and Bidad K: MicroRNAs in rheumatoid arthritis. Clin Rheumatol.
34:615–628. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
MacFarlane LA, Arant KR, Kostic AM, Mass
H, Jones MH, Collins JE, Losina E and Katz JN: Identifying
inflammation in knee osteoarthritis: Relationship of synovial fluid
white blood cell count to effusion-synovitis on magnetic resonance
imaging. Arthritis Care Res (Hoboken). 75:1783–1787.
2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Liu L, Chen H, Jiang T and He D:
MicroRNA-106b overexpression suppresses synovial inflammation and
alleviates synovial damage in patients with rheumatoid arthritis.
Mod Rheumatol. 32:1054–1063. 2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Garrido-Mesa J and Brown MA: T cell
repertoire profiling and the mechanism by which HLA-B27 causes
ankylosing spondylitis. Curr Rheumatol Rep. 24:398–410.
2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Shah NG, Keraliya A, Nunez DB, Schoenfeld
A, Harris MB, Bono CM and Khurana B: Injuries to the rigid spine:
What the spine surgeon wants to know. Radiographics. 39:449–466.
2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Gouveia EB, Elmann D and Morales MS:
Ankylosing spondylitis and uveitis: Overview. Rev Bras Reumatol.
52:742–756. 2012.PubMed/NCBI
|
|
10
|
Yu L, Qu H, Yu Y, Li W, Zhao Y and Qiu G:
LncRNA-PCAT1 targeting miR-145-5p promotes TLR4-associated
osteogenic differentiation of adipose-derived stem cells. J Cel Mol
Med. 22:6134–6147. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang JX, Jing FY, XU YC, Zong HX, Chu YR,
Wang C, Chen KM, Tong WQ, Wang XL and Xu SQ: The potential
regulatory mechanism of lncRNA 122K13.12 and lncRNA 326C3.7 in
ankylosing spondylitis. Front Mol Biosci. 8(745441)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361.
2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lalevée S and Feil R: Long noncoding RNAs
in human disease: Emerging mechanisms and therapeutic strategies.
Epigenomics. 7:877–879. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Han D, Ouyang G, Pan P and Yuan Y:
Upregulated lncRNA-NEF predicts recurrence and poor treatment
outcomes of ankylosing spondylitis. Immun Inflamm Dis.
10(e627)2022.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Li Y, Zhang S, Zhang C and Wang M: LncRNA
MEG3 inhibits the inflammatory response of ankylosing spondylitis
by targeting miR-146a. Mol Cell Biochem. 466:17–24. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liu W, Huang L, Zhang C and Liu Z: lncRNA
MEG3 is downregulated in ankylosing spondylitis and associated with
disease activity, hospitalization time and disease duration. Exp
Ther Med. 17:291–297. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Agashe RP, Lippman SM and Kurzrock R: JAK:
Not just another kinase. Mol Cancer Ther. 21:1757–1764.
2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Rosillo MA, Sánchez-Hidalgo M,
Sánchez-Fidalgo S, Aparicio-Soto M, Villegas I and
Alarcón-de-la-Lastra C: Dietary extra-virgin olive oil prevents
inflammatory response and cartilage matrix degradation in murine
collagen-induced arthritis. Eur J Nut. 55:315–325. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li WQ, Dehnade F and Zafarullah M:
Oncostatin M-induced matrix metalloproteinase and tissue inhibitor
of metalloproteinase-3 genes expression in chondrocytes requires
Janus kinase/STAT signaling pathway. J Immunol. 166:3491–3498.
2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Raychaudhuri SK and Raychaudhuri SP: Janus
kinase/signal transducer and activator of transcription pathways in
spondyloarthritis. Curr Opin Rheumatol. 29:311–316. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ding X, Liu J and Sun Y: Expression of
long non-coding RNA NONHSAT227927.1 and its effect on the
JAK2/STAT3 signaling pathway and inflammation in patients with
ankylosing spondylitis. Exp Ther Med. 25(231)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li XJ, Jiang ZZ and Zhang LY: Triptolide:
Progress on research in pharmacodynamics and toxicology. J
Ethnopharmacol. 155:67–79. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yan P and Sun X: Triptolide: A new star
for treating human malignancies. J Cancer Res Ther. 14
(Suppl):S271–S275. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
American Diabetes Association. Diagnosis
and classification of diabetes mellitus. Diabetes Care. 36 (Suppl
1):S67–S74. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ji W, Lu Y, Ma Z, Gan K, Liu Y, Cheng Y,
Xu J, Liu S, Guo Y, Han S, et al: Triptolide attenuates inhibition
of ankylosing spondylitis-derived mesenchymal stem cells on the
osteoclastogenesis through modulating exosomal transfer of
circ-0110634. J Orthop Translat. 36:132–144. 2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang G, Cai J, Zhang J and Li C: Mechanism
of triptolide in treating ankylosing spondylitis through the
anti-ossification effect of the BMP/Smad signaling pathway. Mol Med
Rep. 17:2731–2737. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
van der Linden S, Valkenburg HA and Cats
A: Evaluation of diagnostic criteria for ankylosing spondylitis. A
proposal for modification of the New York criteria. Arthritis
Rheum. 27:361–368. 1984.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ramiro S, Nikiphorou E, Sepriano A,
Ortolan A, Webers C, Baraliakos X, Landewé RBM, Van den Bosch FE,
Boteva B, Bremander A, et al: ASAS-EULAR recommendations for the
management of axial spondyloarthritis: 2022 Update. Ann Rheum Dis.
82:19–34. 2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Landewé R, Dougados M, Mielants H, van der
Tempel H and van der Heijde D: Physical function in ankylosing
spondylitis is independently determined by both disease activity
and radiographic damage of the spine. Ann Rheum Dis. 68:863–867.
2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Poddubnyy D, Protopopov M, Haibel H, Braun
J, Rudwaleit M and Sieper J: High disease activity according to the
ankylosing spondylitis disease activity score is associated with
accelerated radiographic spinal progression in patients with early
axial spondyloarthritis: Results from the GErman SPondyloarthritis
inception cohort. Ann Rheum Dis. 75:2114–2118. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Qin X, Zhu B, Jiang T, Tan J, Wu Z, Yuan
Z, Zheng L and Zhao J: miR-17-5p regulates heterotopic ossification
by targeting ANKH in ankylosing spondylitis. Mol Ther Nucleic
Acids. 18:696–707. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhong H and Zhong M: LINC00311 is
overexpressed in ankylosing spondylitis and predict treatment
outcomes and recurrence. BMC Musculoskelet Disord.
20(278)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
van der Heijde D, Ramiro S, Landewé R,
Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A,
Dagfinrud H, Dougados M, et al: 2016 update of the ASAS-EULAR
management recommendations for axial spondyloarthritis. Ann Rheum
Dis. 76:978–991. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ward MM, Deodhar A, Gensler LS, Dubreuil
M, Yu D, Khan MA, Haroon N, Borenstein D, Wang R, Biehl A, et al:
2019 update of the American college of rheumatology/spondylitis
association of America/spondyloarthritis research and treatment
network recommendations for the treatment of ankylosing spondylitis
and nonradiographic axial spondyloarthritis. Arthritis Rheumatol.
71:1599–1613. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Li N, Chen Z, Feng W, Gong Z, Lin C, Chen
J, Chu C and Xu Q: Triptolide improves chondrocyte proliferation
and secretion via down-regulation of miR-221 in synovial cell
exosomes. Phytomedicine. 107(154479)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ji W, Liu S, Zhao X, Guo Y, Xia S, Lu Y,
Yin M and Xu X: Triptolide inhibits proliferation, differentiation
and induces apoptosis of osteoblastic MC3T3-E1 cells. Mol Med Rep.
16:7391–7397. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Luo X, Gu Y, Tao X, Serhan CN and Ji RR:
Resolvin D5 inhibits neuropathic and inflammatory pain in male but
not female mice: distinct actions of D-series resolvins in
chemotherapy-induced peripheral neuropathy. Front Pharmacol.
10(745)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hur K, Kim SH and Kim JM: Potential
implications of long noncoding RNAs in autoimmune diseases. Immune
Netw. 19(e4)2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Hamdy SM, Ali MS, Abd El-Hmid RG,
Abdelghaffar NK and Abdelaleem OO: Role of long non coding RNAs,
NEAT1 and Lnc-DC expression in pediatric immune thrombocytopenic
purpura. Rep Biochem Mol Biol. 11:635–643. 2023.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Cai B, Cai J, Yin Z, Jiang X, Yao C, Ma J,
Xue Z, Miao P, Xiao Q, Cheng Y, et al: Long non-coding RNA
expression profiles in neutrophils revealed potential biomarker for
prediction of renal involvement in SLE patients. Rheumatology
(Oxford). 60:1734–1746. 2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Morchikh M, Cribier A, Raffel R, Amraoui
S, Cau J, Severac D, Dubois E, Schwartz O, Bennasser Y and
Benkirane M: HEXIM1 and NEAT1 long non-coding RNA form a
multi-subunit complex that regulates DNA-mediated innate immune
response. Mol Cell. 67:387–399.e5. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Li X, Chai W, Zhang G, Ni M, Chen J, Dong
J, Zhou Y, Hao L, Bai Y and Wang Y: Down-regulation of
lncRNA-AK001085 and its influences on the diagnosis of ankylosing
spondylitis. Med Sci Monit. 23:11–16. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ding M, Guan TJ, Wei CY and Chen BH:
Identification of pathways significantly associated with
spondyloarthropathy/ankylosing spondylitis using the sub-pathway
method. Mol Med Rep. 18:3825–3833. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Marcus DM: Comparison of Tripterygium
wilfordii Hook F with methotrexate in the treatment of
rheumatoid arthritis. Ann Rheum Dis. 73(e56)2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Tao X, Younger J, Fan FZ, Wang B and
Lipsky PE: Benefit of an extract of Tripterygium wilfordii
Hook F in patients with rheumatoid arthritis: A double-blind,
placebo-controlled study. Arthritis Rheum. 46:1735–1743.
2002.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Matta R, Wang X, Ge H, Ray W, Nelin LD and
Liu Y: Triptolide induces anti-inflammatory cellular responses. Am
J Transl Res. 1:267–282. 2009.PubMed/NCBI
|
|
47
|
Chen BJ: Triptolide, a novel
immunosuppressive and anti-inflammatory agent purified from a
Chinese herb Tripterygium wilfordii Hook F. Leuk Lymphoma.
42:253–265. 2001.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Su MX, Zhou WD, Lan J, Di B and Hang TJ:
Rapid and sensitive analysis of multiple bioactive constituents in
tripterygium glycosides tablets using liquid chromatography coupled
with time-of-flight mass spectrometry. J Sep Sci. 38:804–812.
2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Wang QL, Sun M, Wang DT, et al:
Observation on the efficacy of Tripterygium wilfordii
polyglycosides combined with methotrexate in the treatment of
ankylosing spondylitis. World Chin Med. 17:2486–2489. 2002.(In
Chinese).
|
|
50
|
Ji W, Chen Y, Zhao X, Guo Y, Zhong L, Li
H, Wang D and Song Y: Beneficial effects of tripterygium glycosides
tablet on biomarkers in patients with ankylosing spondylitis. Mol
Med Rep. 12:684–690. 2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Ye X, Li W, Yan Y, Mao C, Cai R, Xu H and
Yang X: Effects of cytochrome P4503A inducer dexamethasone on the
metabolism and toxicity of triptolide in rat. Toxicol Lett.
192:212–220. 2010.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Lee HI, Kim HJ, Jo S, Shim SC, Kim TH, Won
EJ and Kim TJ: IL-6 activates pathologic Th17 cell via STAT 3
phosphorylation in inflammatory joint of ankylosing spondylitis.
Biochem Biophys Res Commun. 620:69–75. 2022.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Zhong Z, Wen Z and Darnell JE Jr: Stat3: A
STAT family member activated by tyrosine phosphorylation in
response to epidermal growth factor and interleukin-6. Science.
264:95–98. 1994.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Fang YY, Wan L, Dong WZ, Wen JT and Liu J:
Effect of triptolide in improving platelet activation in patients
with ankylosing spondylitis by regulating VEGFA,SDF-1,CXCR4
pathway. Zhongguo Zhong Yao Za Zhi. 44:3520–3525. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
